Limited Period Offer: Get up to 10% off + extra 15% off on medicines & more offers. Explore
(0) Write a review
In stock

Plaobes Daily Injection (Liraglutide) Effective Weight Loss Pen

Zakres cen: od €125.00 do €210.00

52 people are viewing this right now

Learn about Plaobes® Daily Injection (Liraglutide), a prescription GLP-1 weight management treatment available through licensed healthcare providers in the UK, Germany, Netherlands, Norway, Poland, and Spain. Discover eligibility, benefits, and important safety information.

Buy now
  • Free Shipping Icon SVG Vector & PNG Free Download | UXWingFree Shipping & Returns on this item
  • Delivery within 3-5 working days
  • Money Back Guarantee

Description

Plaobes® Daily Injection (Liraglutide) Weight Loss Pen is a prescription weight management treatment containing liraglutide, a GLP-1 receptor agonist that may help adults manage their weight when used alongside a reduced-calorie diet and increased physical activity. Designed for convenient once-daily administration, Plaobes® comes in a pre-filled injection pen that supports a structured, medically supervised weight management program.

Liraglutide works by mimicking a naturally occurring hormone involved in appetite regulation, helping individuals feel fuller for longer and supporting healthier eating habits. Plaobes® should only be used under the guidance of a qualified healthcare professional.

How Plaobes® (Liraglutide) Works

Plaobes® contains liraglutide, which belongs to a class of medicines known as GLP-1 receptor agonists. These medications act on appetite-regulating pathways to help:

  • Increase feelings of fullness after meals
  • Support appetite control
  • Help reduce overall calorie intake
  • Assist with long-term weight management goals
  • Complement healthy diet and exercise plans

Successful weight management requires ongoing lifestyle modifications in addition to prescribed treatment.

Key Features

  • Contains liraglutide, a GLP-1 receptor agonist
  • Once-daily injectable weight management treatment
  • Convenient pre-filled injection pen
  • Prescription-only medication
  • Supports appetite regulation
  • Designed for use alongside lifestyle changes
  • Healthcare professional supervision required
  • Suitable for eligible adults seeking medical weight management support

Who May Be Eligible?

Plaobes® may be prescribed to adults who:

  • Have obesity according to BMI guidelines
  • Are overweight and have weight-related health concerns
  • Require additional support to achieve weight management goals
  • Have been assessed by a qualified healthcare provider

A medical consultation is required to determine treatment suitability.

Important Safety Information

Plaobes® is a prescription medication and may not be suitable for everyone. Patients should discuss their medical history, current medications, and treatment goals with a licensed healthcare professional before starting therapy. Always follow prescribed dosing instructions and read the patient information leaflet supplied with the medication.

Plaobes® Daily Injection (Liraglutide) Weight Loss Pen

Looking for information about Plaobes® Daily Injection (Liraglutide) Weight Loss Pen in the  Germany, Netherlands, United Kingdom, Norway, Poland, and Spain? Plaobes® is a prescription GLP-1 weight management treatment that contains liraglutide and is designed to support adults who require medical assistance with weight management.

Administered once daily through a pre-filled injection pen, Plaobes® works alongside healthy lifestyle changes to support appetite control and long-term weight management goals. Patients across Europe can discuss treatment eligibility with qualified healthcare professionals according to local prescribing regulations.

Whether you are seeking a medically supervised weight management solution in the UK, Germany, the Netherlands, Norway, Poland, or Spain, Plaobes® offers a convenient daily injection option for eligible adults.

Informacje dodatkowe

Pack size

3 pens, 5 pens

Plaobes FAQs

Plaobes is a daily injectable liraglutide medication for weight management in eligible adults. It belongs to the GLP-1 receptor agonist class — mimicking the natural GLP-1 hormone to slow gastric emptying, reduce appetite signals in the brain, and improve insulin sensitivity. Taken once daily as a self-injection, Plaobes helps you feel fuller for longer and supports sustained weight loss alongside diet and exercise.

Plaobes is available through licensed healthcare providers in the UK, Germany, Netherlands, Norway, Poland, Spain, and other EU countries. EU Slim Store ships Plaobes via temperature-controlled, discreet delivery: Netherlands 2–3 days, Belgium 2–4 days, UK 1–2 days, Germany 3–5 days, France 3–5 days, Poland 4–5 days, Norway 4–6 days, Spain 3–5 days.

Plaobes is appropriate for adults with a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related condition such as type 2 diabetes, high blood pressure, sleep apnoea, dyslipidaemia, or cardiovascular disease. Eligibility is confirmed by a licensed European doctor during your free online consultation, including review of any contraindications.

Plaobes uses a 5-week daily titration to reach the maintenance dose: Week 1 = 0.6 mg, Week 2 = 1.2 mg, Week 3 = 1.8 mg, Week 4 = 2.4 mg, Week 5+ = 3.0 mg (maintenance). The gradual titration minimises gastrointestinal side effects. If you cannot tolerate 3.0 mg, treatment is generally discontinued — lower doses don't produce meaningful weight loss.

Plaobes contains liraglutide, producing average weight loss of 8–12% of starting body weight over 56 weeks at the 3.0 mg maintenance dose. About 33% of patients lose more than 10% of body weight. Results depend on adherence to lifestyle changes, starting weight, and how your body responds to liraglutide.

Plaobes is administered as a once-daily subcutaneous injection in your abdomen, thigh, or upper arm using the pre-filled multi-dose pen. Take it at the same time each day for consistent effects. The needle is very thin — most patients describe the injection as barely noticeable. Rotate injection sites to avoid skin irritation.

The most common side effects are gastrointestinal: nausea (~39% during titration), diarrhoea, constipation, vomiting, and reduced appetite (intended effect). Most resolve within 2–4 weeks of each dose increase. Less common: headache, fatigue, mild injection-site reactions. Serious side effects like pancreatitis are rare but require urgent medical attention.

Plaobes, Saxenda, Biolide, and Nevolat all contain the same active ingredient (liraglutide) at the same doses, with the same mechanism of action and clinical effects. The main differences are brand, pricing, and country availability. Plaobes is particularly well-distributed across UK, Germany, Netherlands, Norway, Poland, and Spain — making it a strong choice for patients in those markets.

Prioritise lean protein, vegetables, whole grains, and adequate water (~2 L daily). Eat smaller, more frequent meals to manage the fullness effect and reduce nausea. Avoid greasy, fried, or very rich foods — particularly during titration and after each dose increase. Limit alcohol, especially during the first weeks of treatment.

If you miss your daily dose, take it as soon as you remember on the same day. If you remember the next day, skip the missed dose and continue your normal schedule. Do NOT take a double dose to compensate. If you miss doses for 3+ consecutive days, contact your doctor — you may need to re-titrate from a lower dose.

Store unopened Plaobes pens in the refrigerator at 2–8 °C in original packaging, away from light. Do not freeze. After first use, pens can be kept at room temperature (below 30 °C) for up to 30 days. Discard after 30 days even if medication remains. Always check the solution before injecting — discard if cloudy or contains particles.

Plaobes is not recommended during pregnancy, while trying to conceive, or while breastfeeding. Stop Plaobes at least 1 month before planned conception. Note that delayed gastric emptying may affect absorption of oral contraceptives — use backup barrier contraception for 4 weeks after starting and after each dose increase.

Without continued treatment, most patients regain a significant portion of lost weight within 12 months of stopping. Your doctor will discuss long-term plans: continuation, gradual reduction, or transitioning to a weekly GLP-1 medication like Wegovy. Lifestyle changes built during treatment help maintain results.

Yes — Plaobes is specifically distributed across these six markets through licensed healthcare providers. EU Slim Store ships Plaobes to all of them following an online consultation. The multi-country authorisation is one reason Plaobes is a particularly accessible option for patients seeking GLP-1 weight loss treatment across Europe.

Plaobes is a daily injection (vs weekly for Wegovy/Mounjaro), produces less average weight loss (8–12% vs 14.9–22.5% for newer GLP-1s), but offers daily dosing flexibility. Some patients prefer daily routines, while others find weekly injections easier to remember. The choice depends on lifestyle preference, side effect tolerance, and budget — your doctor will help you decide.

Reviews

Be the first to review “Plaobes Daily Injection (Liraglutide) Effective Weight Loss Pen”

Twój adres email nie zostanie opublikowany. Wymagane pola są oznaczone *

There are no reviews yet.

Search

Back to Top

Shipping Address

Product has been added to your cart
Compare (0)